17.25

6.88% 1.11

Optimizerx Corp (OPRX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Optimizerx Corp stock is traded at $17.25, with a volume of 367.74K. It is up +6.88% in the last 24 hours and up +29.70% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Previous Close:

$16.14

Open:

$16.28

24h Volume:

367.74K

Relative Volume:

1.16

Market Cap:

$320.25M

Revenue:

$62.81M

Net Income/Loss:

$-13.75M

P/E Ratio:

-21.56

EPS:

-0.8

Net Cash Flow:

$153.00K

1W Performance:

+2.31%

1M Performance:

+29.70%

6M Performance:

+198.44%

1Y Performance:

+107.58%

1-Day Range:

$15.96

$17.30

1-Week Range:

$15.10

$17.30

52-Week Range:

$3.78

$18.22

Optimizerx Corp Stock (OPRX) Company Profile

Name

Optimizerx Corp

Sector

Healthcare (1157)

Industry

Health Information Services (54)

Phone

248-651-6558

Address

260 CHARLES STREET, WALTHAM, MI

Employee

129

Twitter

@OpRxTweets

Next Earnings Date

2025-03-12

Latest SEC Filings

OPRX's Discussions on Twitter

Compare OPRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPRX Optimizerx Corp	17.25	315.23M	62.81M	-13.75M	153.00K	-0.80
VEEV Veeva Systems Inc	290.86	46.10B	2.86B	780.66M	1.19B	4.72
TEM Tempus Ai Inc	80.52	13.63B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	67.74	12.35B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	89.82	7.74B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	36.24	6.32B	906.14M	-52.62M	89.62M	-0.3621

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Dec-20-24	Initiated	Stephens	Equal-Weight
Jul-25-24	Resumed	B. Riley Securities	Buy
Apr-04-24	Initiated	JMP Securities	Mkt Outperform
Jan-03-24	Initiated	Barclays	Equal Weight
Feb-02-23	Resumed	B. Riley Securities	Buy
Nov-01-22	Initiated	Stifel	Buy
Jul-15-22	Initiated	SVB Leerink	Outperform
Oct-18-21	Resumed	B. Riley Securities	Buy
Apr-13-21	Initiated	RBC Capital Mkts	Outperform
Jan-03-19	Initiated	William Blair	Outperform

View All

Optimizerx Corp Stock (OPRX) Latest News

Aug 20, 2025

OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Aug 20, 2025

Aug 19, 2025

OptimizeRx announces leadership reorganization to drive growth strategy - Investing.com

Aug 19, 2025

OptimizeRx Corp. Announces Leadership Changes to Enhance Growth Strategy and Profitability - Quiver Quantitative

Aug 19, 2025

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth - MarketScreener

Aug 19, 2025

Major C-Suite Overhaul: OptimizeRx Names 6 Top Executives to New Roles in Healthcare Tech Growth Push - Stock Titan

Aug 19, 2025

Aug 17, 2025

OptimizeRx Corporation Attempts Reversal From Key SupportQuarterly Performance Summary & Reliable Entry Point Alerts - 선데이타임즈

Aug 17, 2025

Regression analysis insights on OptimizeRx Corporation performanceMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser

Aug 17, 2025

Aug 16, 2025

How moving averages guide OptimizeRx Corporation tradingWeekly Profit Summary & Step-by-Step Swing Trade Plans - Newser

Aug 16, 2025

Short interest data insights for OptimizeRx CorporationGlobal Markets & Reliable Intraday Trade Plans - Newser

Aug 16, 2025

OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Aug 16, 2025

Aug 15, 2025

JMP Securities Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - MarketBeat

Aug 15, 2025

Trend analysis for OptimizeRx Corporation this weekWeekly Profit Analysis & Verified Swing Trading Watchlists - Newser

Aug 15, 2025

Can you recover from losses in OptimizeRx Corporation2025 Key Lessons & Weekly High Potential Stock Alerts - Newser

Aug 15, 2025

Aug 14, 2025

Will breakout in OptimizeRx Corporation lead to full recoveryJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser

Aug 14, 2025

Aug 13, 2025

What technical models suggest about OptimizeRx Corporation’s comebackForecast Cut & Stock Market Timing Techniques - Newser

Aug 13, 2025

OptimizeRx’s SWOT analysis: digital health firm’s stock faces scaling hurdles - Investing.com

Aug 13, 2025

OptimizeRx Reports 55% YoY Revenue Growth, Raises 2025 Guidance - AInvest

Aug 13, 2025

OptimizeRx (NASDAQ:OPRX) Given New $18.00 Price Target at Stifel Nicolaus - MarketBeat

Aug 13, 2025

Aug 12, 2025

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 12, 2025

Is OptimizeRx Corporation stock bottoming outTechnical Trend Forecast for Investors - Newser

Aug 12, 2025

Aug 11, 2025

OptimizeRX price target raised to $20 from $14 at JMP on strong earnings - Investing.com Nigeria

Aug 11, 2025

Aug 10, 2025

What makes OptimizeRx Corporation stock price move sharplySwing Trade Timing with Daily Forecast - Newser

Aug 10, 2025

Using AI based signals to follow OptimizeRx CorporationSteady Return Plan Based on Data Analysis - Newser

Aug 10, 2025

Should you hold or exit OptimizeRx Corporation nowTechnical Screener for High Growth Stocks - Newser

Aug 10, 2025

Blair William & Co. IL Buys 29,648 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat

Aug 10, 2025

Applying Elliott Wave Theory to OptimizeRx CorporationShort Term Gain Strategy with AI Logic - Newser

Aug 10, 2025

Aug 09, 2025